Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A comprehensive intervention to enhance inpatient colon preparation quality for colonoscopy.1 passage
• Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient.1 passage
• Beyond biologics: advanced therapies in inflammatory bowel diseases.1 passage
• Chronic hepatitis B virus infection and fibrosis: novel non-invasive approaches for diagnosis and risk stratification.1 passage
• Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma.1 passage
• Digital single‑operator cholangioscopy in treating difficult biliary stones: results from a multicenter experience.1 passage
• Does completing advanced endoscopy fellowship improve outcomes after endoscopic mucosal resection?1 passage
• Does faecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?1 passage
• Drug induced liver injury: from pathogenesis to liver transplantation.1 passage
• EUS-guided ablation of pancreatic neoplasms.1 passage
• Elastography for characterization of focal liver lesions: current evidence and future perspectives.1 passage
• Endoscopic changes in patients diagnosed with acute pancreatitis.1 passage
• Endoscopic management of difficult common bile duct stones.1 passage
• Endoscopic ultrasonography (EUS) -guided visceral anastomoses: indications and techniques.1 passage
• Epidemiology and clinical course of late onset inflammatory bowel disease.1 passage
• Fatigue, sarcopenia, and frailty in older adults with Inflammatory Bowel Disease.1 passage
• Gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis.1 passage
• Genetic and environmental factors influencing the interaction between the gut microbiota and the human host: implications for gastrointestinal disorders and treatment approaches.1 passage
• Gut microbiota and non-alcoholic fatty liver disease: a narrative review.1 passage
• Hepatitis B virus infection and risk of gastric cancer: a systematic review and meta-analysis.1 passage
• Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy.1 passage
• Histology of ibd and related colitides in the elderly.1 passage
• Immune system and gut microbiota senescence in elderly IBD patients.1 passage
• Impact of E-cadherin and its transcription regulators on assessing epithelial-mesenchymal transition in chronic hepatitis C virus infection.1 passage
• Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C.1 passage
• Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C.1 passage
• Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.1 passage
• Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C.1 passage
• Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C.1 passage
• Implications of gut microbiota in autoimmune liver diseases.1 passage
• Interplay of potassium channel, gastric parietal cell and proton pump in gastrointestinal physiology, pathology and pharmacology.1 passage
• Intestinal perforations after endoscopic retrograde cholangiopancreatography in the USA: a 16-year study using the National Inpatient Sample.1 passage
• Irritable bowel syndrome and lactose intolerance: the importance of differential diagnosis. A monocentric study.1 passage
• Liver and spleen elastography as predictor of portal hypertension and esophageal varices.1 passage
• Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature.1 passage
• Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet is associated with increased risk of uninvestigated chronic dyspepsia and its symptoms in adults.1 passage
• Malnourished cirrhotic patient: what should we do?1 passage
• Management of portal hypertension severe complications.1 passage
• Microbiota and the irritable bowel syndrome.1 passage
• Nutraceuticals & microbiota: review.1 passage
• Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists.1 passage
• Peroral endoscopic myotomy (POEM) for esophageal diverticula.1 passage
• Probiotics and gut health.1 passage
• Quercetin Phytosome® as a potential candidate for managing COVID-19.1 passage
• Renal dysfunctions and liver disease: a brief update on management with particular attention to hepatorenal syndrome.1 passage
• Rheumatic manifestations in inflammatory bowel disease.1 passage
• Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of long-term survival and urogenital functional outcomes.1 passage
• Role of CH-EUS as guidance for EUS-biliary drainage malignant obstruction.1 passage
• Role of endoscopic ultrasonography in the management of peripancreatic collections. Diagnostic and therapeutic approach.1 passage
• Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.1 passage
• Safety issues in endoscopy ultrasound-guided interventions using lumen apposing metal stents: a review of the literature.1 passage
• Severe acute alcoholic hepatitis: can we offer early liver transplantation?1 passage
• Small bowel capsule endoscopy: where do we stand after 20 years of clinical use?1 passage
• Substances use disorders and liver injury: a concise review.1 passage
• The GLU-10: a validated ten-point score to identify poorly instructed coeliac patients in need of dietary interventions.1 passage
• The association between irritable bowel syndrome and ischemic colitis: a systematic review and meta-analysis.1 passage
• The effects of dietary intervention on fibrosis and biochemical parameters in metabolic-associated fatty liver disease.1 passage
• The efficacy of fasting regimens on health outcomes: a systematic overview.1 passage
• The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C.1 passage
• The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature.1 passage
• The role of elastography in non-alcoholic fatty liver disease.1 passage
• The role of elastography in viral hepatitis and autoimmune hepatitis.1 passage
• The role of liver and spleen elastography in advanced chronic liver disease.1 passage
• The role of telemedicine in the management of inflammatory bowel disease: a systematic review protocol.1 passage
• Therapy in elderly IBD patients.1 passage
• Training in advanced bilio-pancreatic endoscopy.1 passage
• Treatment of acute cholecystitis in high-risk surgical patients. Systematic review of the literature according to the levels of evidence.1 passage
• Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease.1 passage